IMC Chicago’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.12M Sell
281,300
-2,400
-0.8% -$46.5K ﹤0.01% 1626
2025
Q4
$6.11M Buy
283,700
+208,700
+278% +$4.4M ﹤0.01% 1589
2025
Q3
$1.45M Buy
75,000
+43,300
+137% +$772K ﹤0.01% 2464
2025
Q2
$542K Buy
31,700
+3,500
+12% +$149K ﹤0.01% 2814
2025
Q1
$1.8M Buy
+28,200
New +$2.97M ﹤0.01% 1864
2024
Q3
Sell
-12,000
Closed -$1.9M 3030
2024
Q2
$1.9M Buy
+12,000
New +$1.54M ﹤0.01% 1577
2024
Q1
Sell
-20,100
Closed -$1.94M 2495
2023
Q4
$1.94M Sell
20,100
-100
-0.5% -$9.59K ﹤0.01% 1225
2023
Q3
$2.45M Sell
20,200
-1,700
-8% -$192K ﹤0.01% 924
2023
Q2
$2.51M Sell
21,900
-52,800
-71% -$6.81M ﹤0.01% 823
2023
Q1
$10.3M Buy
74,700
+46,400
+164% +$6.02M 0.01% 483
2022
Q4
$3.67M Buy
28,300
+15,200
+116% +$1.76M 0.01% 686
2022
Q3
$1.45M Buy
+13,100
New +$1.32M ﹤0.01% 825
2022
Q1
Sell
-29,900
Closed -$2.69M 1246
2021
Q4
$2.69M Sell
29,900
-200
-0.7% -$17.1K ﹤0.01% 749
2021
Q3
$2.78M Sell
30,100
-3,900
-11% -$300K ﹤0.01% 775
2021
Q2
$2.64M Sell
34,000
-23,600
-41% -$1.79M ﹤0.01% 712
2021
Q1
$4.29M Buy
57,600
+23,800
+70% +$2.2M 0.01% 600
2020
Q4
$5.76M Buy
33,800
+18,800
+125% +$2.79M 0.01% 516
2020
Q3
$2.11M Buy
15,000
+3,400
+29% +$517K ﹤0.01% 575
2020
Q2
$1.86M Sell
11,600
-4,400
-28% -$599K ﹤0.01% 577
2020
Q1
$1.56M Sell
16,000
-26,500
-62% -$3.03M ﹤0.01% 555
2019
Q4
$5.48M Buy
42,500
+20,400
+92% +$2.06M 0.01% 325
2019
Q3
$1.67M Sell
22,100
-15,500
-41% -$1.83M 0.01% 490
2019
Q2
$5.71M Sell
37,600
-15,200
-29% -$1.85M 0.02% 256
2019
Q1
$6.29M Buy
+52,800
New +$6.79M 0.02% 208

Other funds holding SRPT